Search

Lynne M Sole

from Billerica, MA
Age ~66
Get Report
Also known as:
Sole Lm
Phone and address:
19 Broadleaf St, Billerica, MA 01821
Related to:
Malcolm Sole
Connected to:
Alejandro Sole, 43Amy J Sole, 50Cheryl L Sole, 66David G Sole, 76Debora A Sole, 70Elizabeth L Sole, 41Emily M Sole, 38Joaquin A Sole, 37Jonathan E Sole, 56Kathleen P Sole, 67

Lynne Sole Phones & Addresses

  • 19 Broadleaf St, Billerica, MA 01821
  • Southborough, MA

Publications

Us Patents

Pharmaceutical Compositions

View page
US Patent:
20090155368, Jun 18, 2009
Filed:
Dec 12, 2008
Appl. No.:
12/314554
Inventors:
Stephen Randall Holmes-Farley - Arlington MA, US
David J. Harris - Lexington MA, US
Steven C. Polomoscanik - Bedford MA, US
Adnan Salameh - Waltham MA, US
Bruce Shutts - Bolton MA, US
Richard Silva - Needham MA, US
Pradeep K. Dhal - Westford MA, US
Lynne Sole - Billerica MA, US
Assignee:
Genzyme Corporation - Cambridge MA
International Classification:
A61K 9/14
A61K 31/785
A61P 1/00
US Classification:
424489, 424 7808
Abstract:
The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 μm, and used for treating patients, for example, patients with hyperphosphatemia.

Pharmaceutical Compositions

View page
US Patent:
20190240252, Aug 8, 2019
Filed:
Feb 4, 2019
Appl. No.:
16/267238
Inventors:
- Cambridge MA, US
David J. HARRIS - Lexington MA, US
Steven C. POLOMOSCANIK - Bedford MA, US
Adnan SALAMEH - Irvine CA, US
Bruce SHUTTS - Bolton MA, US
Richard SILVA - Needham MA, US
Pradeep K. DHAL - Westford MA, US
Lynne SOLE - Billerica MA, US
International Classification:
A61K 31/785
B01J 41/14
A61K 9/20
A61K 9/16
A61K 9/28
A61K 9/14
Abstract:
The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 μm, and used for treating patients, for example, patients with hyperphosphatemia.

Pharmaceutical Compositions

View page
US Patent:
20160158275, Jun 9, 2016
Filed:
Dec 14, 2015
Appl. No.:
14/968170
Inventors:
- Cambridge MA, US
David J. HARRIS - Lexington MA, US
Steven C. POLOMOSCANIK - Bedford MA, US
Adnan SALAMEH - Irvine CA, US
Bruce SHUTTS - Bolton MA, US
Richard SILVA - Needham MA, US
Pradeep K. DHAL - Westford MA, US
Lynne SOLE - Billerica MA, US
International Classification:
A61K 31/785
A61K 9/20
B01J 41/14
A61K 9/16
Abstract:
The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 μm, and used for treating patients, for example, patients with hyperphosphatemia.

Pharmaceutical Compositions

View page
US Patent:
20140322319, Oct 30, 2014
Filed:
Apr 17, 2014
Appl. No.:
14/255368
Inventors:
- CAMBRIDGE MA, US
David J. HARRIS - Lexington MA, US
Steven C. POLOMOSCANIK - Bedford MA, US
Adnan SALAMEH - Irvine CA, US
Bruce SHUTTS - Bolton MA, US
Richard SILVA - Needham MA, US
Pradeep K. DHAL - Westford MA, US
Lynne SOLE - Billerica MA, US
Assignee:
GENZYME CORPORATION - CAMBRIDGE MA
International Classification:
A61K 31/785
A61K 9/28
A61K 9/20
US Classification:
424464, 424 7826, 5253283, 428402
Abstract:
The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 μm particles and used for treating patients, for example, patients with hyperphosphatemia.
Control profile
Lynne M Sole from Billerica, MA, age ~66 Get Report